Episodios

  • Episode 37: Imaging Research Makes Real Impact
    Mar 18 2026

    Dr. Yashbir Singh sits down with Dr. Lacey McNally to explore her groundbreaking work advancing contrast agents, molecular imaging, and first‑in‑human clinical trials. Together, they discuss the challenges of translational research, the essentials of high‑quality imaging manuscripts, and the evolving landscape of scientific publishing.

    Radiology: Imaging Cancer

    Más Menos
    21 m
  • Episode 36: Detecting Liver Cancer Earlier
    Feb 18 2026

    Dr. Yash Singh sits down with Dr. Sudhakar Venkatesh to explore his global journey in radiology and how innovations like MR elastography are transforming the noninvasive diagnosis and staging of liver disease. They discuss the future of quantitative, AI-enhanced imaging in detecting liver cancer and biliary diseases earlier—shifting radiology from passive observation to a central, collaborative force in precision medicine.

    Radiology: Imaging Cancer special collection for Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine, and Hepatobiliary Cancers.

    Más Menos
    16 m
  • Episode 35: RSNA2025 Insights: Trends, Tech, and Takeaways
    Jan 21 2026

    In this episode, Tom DeSilvio, Brennan Flannery, and Yash Singh reflect on their experiences as trainee editorial board members, discussing what they've learned about peer review, clinical relevance, and evaluating innovation in cancer imaging research. They also share highlights from attending RSNA in person, including emerging trends like AI integration, foundation models, and the value of community and collaboration in radiology.

    Radiology: Imaging Cancer

    Más Menos
    25 m
  • Episode 34: Designing Better Data for Better Care
    Dec 23 2025

    Brennan Flannery and Thomas DeSilvio sit down with Pallavi Tiwari to explore how AI is transforming medical imaging toward more individualized and precise care. The conversation dives into imaging the individual, trust in AI systems, and what the future holds for translating advanced models into real-world clinical impact.
    Radiology: Imaging Cancer

    Más Menos
    31 m
  • Episode 33: Technology, Equity, and Early Detection for Breast Cancer
    Nov 14 2025

    Dr. Yashbir Singh talks with Dr. Bonnie Joe about her journey from engineering to breast imaging and how a systematic, analytical approach shapes her clinical practice. Dr. Joe shares insights on breast screening guidelines, dense breast management, health equity, and how AI could help close gaps in access to care.

    Radiology: Imaging Cancer

    R&E Foundation

    Más Menos
    26 m
  • Episode 32: Imaging Metabolism and Personalized Cancer Care
    Oct 22 2025

    Drs. Ghazal Zandieh, Yash Singh, Thomas DeSilvio, and Brennan Flannery speak with Dr. Joseph Ippolito about how metabolic imaging is transforming cancer diagnosis and treatment through advanced PET and MRI techniques. Together they explore how personalized medicine and sex-specific metabolic differences are reshaping the way radiologists understand and treat glioblastoma.

    Radiology: Imaging Cancer Journal

    Más Menos
    22 m
  • Episode 31: Imaging the Individual in Modern Oncology
    Sep 10 2025

    In this episode, we begin with a brief introduction of our podcasters, Tom DeSilvio, Brennan Flannery, Yash Singh, and Ghazal Zandieh, before welcoming Dr. Gary Luker, Editor‑in‑Chief of the RSNA journal, Radiology: Imaging Cancer. Our goal is to showcase and better introduce the journal while highlighting the future of individualized cancer imaging. Dr. Luker joins us to discuss how advanced imaging, artificial intelligence, and translational research are transforming personalized cancer care.

    Radiology: Imaging Cancer Journal

    Más Menos
    31 m
  • Episode 30: Imaging of Gastrointestinal Graft-Versus-Host Disease
    Mar 7 2025

    Dr. Brandon K.K. Fields speaks with Dr. Jennifer Holter-Chakrabarty about her groundbreaking research on fluorine-18 fluorothymidine (FLT) PET in the imaging of gastrointestinal graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Together, they explore a potential future role for FLT-PET in detection of early and/or subclinical GVHD, which may serve to guide future treatment strategies for transplant patients in years to come.

    18F-FLT PET and Blood-based Biomarkers for IdentifyingGastrointestinal Graft versus Host Disease after Allogeneic CellTransplantation. Holter-Chakrabarty and McNally et al. Radiology: Imaging Cancer 2025; 7(1):e240096.

    Más Menos
    16 m